Shoulder Innovations, Inc. (NYSE: SI) is a Healthcare company (Medical - Specialties) with a market capitalization of $430M. The Maz Rating grades it against the other companies in its sector.
Shoulder Innovations, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $20.56, Shoulder Innovations, Inc. trades at 6.7x sales and 3.6x book value. Over the last twelve months it generated about $64M of revenue and a net loss of $34M. It runs a gross margin of 77.8%, an operating margin of -54.4% and a net margin of -51.7%. It shows return on equity of -25.8%, return on invested capital of -26.3% and a free cash flow yield of -9.9%. On the balance sheet: a debt-to-equity ratio of 0.13 and a current ratio of 10.68. Over the past 52 weeks the share price ranged from $12.00 to $24.60, with a beta of -1.77.
Shoulder Innovations, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Shoulder Innovations, Inc. (SI) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 3.65% / 30% · (Cash+Inv) / Mkt Cap (36m) 22.7% / 30% · Interest income / Revenue 3.55% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 3.65% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 22.7% / 33% · Receivables / Mkt Cap (36m) 2.28% / 49% · Interest income / Revenue 3.55% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 3.65% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 22.7% / 33.33% · Receivables / Mkt Cap (24m) 2.28% / 33.33% · Interest income / Revenue 3.55% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 9.48% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 67.6% / 33.33% · Receivables / Avg Assets (4Q) 6.21% / 33.33% · Interest income / Revenue 3.55% / 5% | Fail |
| FTSE | Debt / Total Assets 10.2% / 33.33% · (Cash+ST Inv) / Total Assets 63.4% / 33.33% · (Cash+Recv) / Total Assets 69.8% / 33.33% · Interest income / Revenue 3.55% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Shoulder Innovations, Inc. (SI) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Shoulder Innovations, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 3.55% of each dividend: Shoulder Innovations, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.